Cargando…

Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types

In order to gain a better understanding of the underlying biology of squamous cell carcinoma (SCC), we tested the hypothesis that SCC originating from different organs may possess common molecular alterations. SCC samples (N = 361) were examined using clinical-grade targeted next-generation sequenci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwaederle, Maria, Elkin, Sheryl K, Tomson, Brett N, Carter, Jennifer Levin, Kurzrock, Razelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613537/ https://www.ncbi.nlm.nih.gov/pubmed/26030731 http://dx.doi.org/10.1080/15384101.2015.1053669

Ejemplares similares

Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testing
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Genomic landscape of salivary gland tumors
por: Kato, Shumei, et al.
Publicado: (2015)

Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics
por: Cohen, Philip R., et al.
Publicado: (2016)

Telomerase Reverse Transcriptase Promoter Alterations Across Cancer Types as Detected by Next-Generation Sequencing: A Clinical and Molecular Analysis of 423 Patients
por: Schwaederle, Maria, et al.
Publicado: (2017)

Actionability and precision oncology
por: Schwaederle, Maria, et al.
Publicado: (2015)

Next generation sequencing demonstrates association between tumor suppressor gene aberrations and poor outcome in patients with cancer
por: Schwaederle, Maria, et al.
Publicado: (2015)

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications
por: Helsten, Teresa, et al.
Publicado: (2015)

Analysis of MDM2 Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies
por: Kato, Shumei, et al.
Publicado: (2018)

An appraisal of drug development timelines in the Era of precision oncology
por: Jardim, Denis Leonardo, et al.
Publicado: (2016)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients
por: Heestand, Gregory M., et al.
Publicado: (2017)

Next-generation sequencing revealed synchronous double primary lung squamous carcinoma: a case report
por: Yang, De-Song, et al.
Publicado: (2021)

Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials
por: Galanina, Natalie, et al.
Publicado: (2018)

TP53 mutations and number of alterations correlate with maximum standardized uptake value (SUVmax) determined by positron emission tomography/computed tomography (PET/CT) [(18)F] fluorodeoxyglucose ((18)F-FDG PET)
por: Chang, Geraldine H., et al.
Publicado: (2018)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Gene mutations of esophageal squamous cell carcinoma based on next-generation sequencing
por: Wang, Long, et al.
Publicado: (2021)

Next generation sequencing-based salivary biomarkers in oral squamous cell carcinoma
por: Sodnom-Ish, Buyanbileg, et al.
Publicado: (2022)

Diagnosis of lung squamous cell carcinoma based on metagenomic Next-Generation Sequencing
por: Wei, Ping, et al.
Publicado: (2022)

Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing
por: Janku, Filip, et al.
Publicado: (2014)

Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance
por: Wheler, Jennifer, et al.
Publicado: (2015)

HER2 expression status in diverse cancers: review of results from 37,992 patients
por: Yan, Min, et al.
Publicado: (2015)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Clinical Application of Next-generation Sequencing for the Diagnosis of Lung Squamous Cell Carcinoma: Is It Primary or Secondary?
por: Aizawa, Hiroaki, et al.
Publicado: (2020)

Assessment of the Mutation Profile of Tonsillar Squamous Cell Carcinomas Using Targeted Next-Generation Sequencing
por: Park, Ha Young, et al.
Publicado: (2023)

An Integrated Inspection of the Somatic Mutations in a Lung Squamous Cell Carcinoma Using Next-Generation Sequencing
por: Stead, Lucy F., et al.
Publicado: (2013)

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
por: Lim, Sun Min, et al.
Publicado: (2019)

Oral acantholytic squamous cell carcinoma shares clinical and histological features with angiosarcoma
por: Driemel, Oliver, et al.
Publicado: (2008)

Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinoma
por: Chen, Yang, et al.
Publicado: (2020)

Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival
por: Kato, Shumei, et al.
Publicado: (2019)

Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma
por: Kloss-Brandstätter, Anita, et al.
Publicado: (2015)

Using GBrowse 2.0 to visualize and share next-generation sequence data
por: Stein, Lincoln D.
Publicado: (2013)

Next generation mouse models of squamous cell lung cancer for translational immuno-oncology
por: Hai, Josephine
Publicado: (2020)

Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors
por: Lechner, Matthias, et al.
Publicado: (2013)

Mutation allele frequency threshold does not affect prognostic analysis using next-generation sequencing in oral squamous cell carcinoma
por: Ma, Jie, et al.
Publicado: (2018)

Next Generation Sequencing for Potential Regulated Genes and Micro-RNAs of Early Growth Response-1 in the Esophageal Squamous Cell Carcinoma
por: Tseng, Yen-Chiang, et al.
Publicado: (2022)

Cyclin alterations in diverse cancers: outcome and co-amplification network
por: Schwaederlé, Maria, et al.
Publicado: (2014)

Revealing the Complexity of Breast Cancer by Next Generation Sequencing
por: Verigos, John, et al.
Publicado: (2015)

Next-Generation Sequencing Reveals the Progression of COVID-19
por: Chen, Xiaomin, et al.
Publicado: (2021)

Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing
por: Boichard, Amélie, et al.
Publicado: (2020)

Next-Generation Sequencing at High Sequencing Depth as a Tool to Study the Evolution of Metastasis Driven by Genetic Change Events of Lung Squamous Cell Carcinoma
por: Mansour, Hicham, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5g8r5cme33ojgasuqtq4kef9hh